INTRODUC~ION
Application of immunology to the fields of toxicology and toxicologic pathology is one method employed to examine target organ toxicity as well as generalized toxicity at the cellular and molecular levels (3). The immune system is highly sensitive to toxicants because of both the rapid and specific cellular proliferation induced during an immune response and because of the highly regulated nature of the immune system. Examples of immune dysfunctions include imunosuppression, hypersensitivity, formation of immune complexes, lymphoreticular neoplasia, and development of autoimmune phenomena (14) . In light of the above, risk assessment becomes a difficult task indeed. Unfortunately, no single immunologic assay will encompass all of the possible derangements. For this reason, a number of investigators (3, 14, 15, 18) have recommended a multitiered approach to immunotoxicology. One type of flow chart is outlined in Table I . The importance of histopathologic examination of lymphoid tissues, particularly in subacute or chronic studies as an initial screening procedure, cannot be over-emphasized. Once an indication of toxicity is obtained, further evaluation is warranted. This review will describe one approach to evaluation of immune function both in vivo and in vitro. Many of the techniques described were developed for dogs, although rodents are the species commonly used in toxicology studies. Nonetheless, the principles and approach are consistent with the theme of this symposium on immunotoxicity. 
IN VIVO EVALUATION OF IMMUNE F U N~I O N
Two general approaches to evaluation of immune functions in viw can be employed as a part of the toxicant screening process. The passive approach includes performance of routine hematology profiles, immunoglobulin (Ig) quantitation, and identification and quantitation of mononuclear setshubsets using labeled cell surface marker reagents. Active evaluation implies either intentional immunization or exposure of subject animals to test immunogens with subsequent quantitation of the response. In this instance, time and dose-related immune phenomena can be measured.
Passive El*aliiation. It is obvious that significant alterations in myeloid series values in test subjects are strong indications ofan immunointoxicant event. Alterations in Ig levels in serum, excretions and secretions also indicate underlying abnormalities. For the latter, Ig levels are most easily determined by application of radial immunodiffusion assay (9), in which Ig-class-specific antibody (1% v/v), is incorporated into a 3% agarose gel. Lateral diffusion of Ig from 5-10 p1 cut wells will continue until equivalence. Rings of precipitation can be visualized by indirect lighting or by drying and staining the gels with Coomassie blue stain. Diameter is proportional to concentration and unknowns can be determined by standard curves. Kits are commercially available (Miles Laboratories, Inc.) for RID analysis for canine IgG, IgM and IgA.
Active Evaluation. Interventional approaches to evaluation of immunomodulators are useful in the further delineation of immune alterations. For rodents, in vivo responses to immunogens such as bacterial lipopolysaccharide or dextran sulfate are well established measures of B-cell (independent of T-cell influence) integrity. Immune responses to keyhole 276 limpet hemocyanin (7) or sheep erythrocytes will determine the viability of helper T-cell functions. For the latter, plaque-forming assays for JgG-and IgM-secreting plasma cells in splenocyte suspensions provide quantitative data on the response. A pure T-cell response can be measured by in vitro and in vivo (Le., skin test or foot pad) responses to tuberculin or ppd in Mjrobacteria sp. sensitized animals. Allograft rejection responses are also generally recognized as T-cell dependent. Time-dependent carbon clearance assay is useful in the evaluation of the systemic reticuloendothelial (macrophage) system. Antibody responses to soluble immunogens are best measured by either radioimmune or ELISAbased assay. The latter has the advantage of ease of use and freedom for radioactive substrates. In our laboratory, Ig-class-dependent responses to immunogens can be easily assessed using horseradish peroxidase-conjugated IgG fractions (6) of rabbit or goat anti-immunoglobulins. Recrystallized 5-amino salicylic acid (4) is an excellent, stable and noncarcinogenic substrate chromagen for horseradish peroxidase enzyme.
IN VITRO ASSAYS OF IMMUNE FUNCTION
Isolatioit aid Ciiltiu-e of Iiitiiiiiiie Cells. The most convenient starting source of immune cells is unclotted (heparinized or EDTA-treated) peripheral blood. Single cell suspensions of spleen, lymph node and thymus are easily prepared by pressing organ fragments through wire mesh screens or sterile, gauze-covered beakers. Enrichment for leukocytes is accomplished by Ficoll-Hypaque (FH) gradient separation. For dogs, peripheral blood leukocytes (PBL) are isolated by centrifugation at 400 x g for 40 minutes using FH at 1.080 specific gravity. For adherence assays, it is frequently desirable to remove platelets from PBL preparation. This can be accomplished by glass bead defibrination prior to FH or by employing a platelet depletion centrifugation on EDTA-chelated blood prior to FH separation (1).
Microtiter plate (96-well) iiz vitro culture of leukocytes for in vitro assessment of general and antigen-specific immune functions is a routine immunologic procedure, in which lymphocytes are adjusted to 1-2 x lo6 viable cells per ml in lymphocyte culture medium. In our laboratory, RPMI-1640 medium, supplemented with 1-1'5% autologous or 15-20% fetal calf serum, 1% (dv) glutamine and bicarbonate, is routinely used. Long-term cultures contain Hepes buffer and M 2-mercaptoethanol. Serum free medium, for example, HB-103 (Hana Biologics), minimizes the influence of serum components on in sitro leukocyte perfor- Qtiarititatiori and IdeiitiJicatiori of Leukocyte Populations. By far the most accurate and reproducible method for quantitating cellular (sub)populations is via fluorescence activated cell sorting (FACS) combined with monoclonal antibodies of defined subset binding capabilities. Reagents are available for human, rodent and some populations of the bovine, ovine and porcine species. Although canine lymphocyte monoclonals are being developed by many laboratories, at this writing none are widely available. We have found that a canine Thy-1 (pan-T), available from Sero-Tech Limited, works quite well as a pan T-cell marker (1 2). Some monoclonals to human Ia determinants also react with canine cells. In the absence ofmonoclonals and a FACS machine, a series of more conventional immunologic procedures can be employed. Afoiiocytes/hfacropkages. The easiest method for isolating canine monocytes/macrophages from leukocyte preparations is to take advantage of their propensity to adhere to glass or plastic surfaces. For this, isolated PBL (5 x lo6 cells/ml) are allowed to settle onto plastic culture vessels for 4 hours at 37°C. Nonadherent cells are decanted and adherent cells are gently washed with 3 changes of saline solution. Monocytes can be isolated directly from PBL in 90% purity by centrifugation in hypertonic salt solutions (J. R. Bloom, personal communication, 1986) using a procedure developed by Recalde (16) . We have not yet tried this technique. Once isolated, purity is assessed by cytochemical staining for serine esterase (brown-red reaction product is diffusely distributed in the cytoplasm) or by immunocytochemical staining for lysozyme (19) . Macrophages possess cell membrane receptors for Fc-IgG and C3b. Viable cells can be tentatively identifiedhy their ability to form nonimmune rosettes with IgG-coated erythrocytes (EA) and/or IgM murine complement-coated erythrocytes (EAC). We have found that latex bead (0.794 pm) ingestion conveniently identifies mononuclear phagocytes (1 0), while noting that EAC are frequently internalized in monocyte preparations, whereas EA complexes are not. Combinations of the above methods can be used to assess multiple markers simultaneously (Fig. 1) .
Macrophages are known to synthesize a number of biologically important proteins including those of the coagulation and complement systems. Direct or indirect immunocytochemical assays with defined antisera can be used not only to mark these cells, but also to assess their proper functioning. Macrophages also synthesize an immunologically important molecule, interleukin-1 (IL-1). Production and release of IL-1 can be induced by in vitro exposure of monocytes to E. coli-derived lipopolysaccharide along with indomethacin, a prostaglandin inhibitor (2, 13). Bioassay for released IL-1 is accomplished by 48-hour iiz vitro culture of IL-1 supernatants with canine thymocytes stimulated with PHA-P. Both fresh and cryopreserved thymocytes are effective; for the latter, nonviable cells are removed by FH separation prior to culture. Interleukin-1, if present in supernatant, is detected by enhanced blastogenesis.
B-Lymphocytes. Leukocytes of the B-cell lineage
are directly concerned with the production of immunoglobulin. In dogs, 5-20°/o of circulating non-macrophage mononuclear cells are of B-cell origin. Direct identification of B-cells is best accomplished by surface labeling with anti-globulin reagents. In this procedure, cells isolated in FH are resuspended in HBSS containing 0.01% sodium azide (19) . The azide prevents translational movement and subsequent internalization and/or shedding of cell membrane-bound Ig. This can also be done by performing the assay at 0-4°C in an ice bath. To avoid Fc-mediated binding of anti-globulin reagents by non-By Fc-positive cells, an F(ab),-labeled secondary reagent should be used. Ifthese are not available, filtration (0.22 pm) of reagent prior to use will minimize nonspecific binding. Fluorescein-labeled reagents are commercially available.
One direct in vitro measure of B-cell function is their ability to differentiate into Ig-secreting plasma cells (5, 12). Monocyte-depleted leukocyte preparations are cultured with pokeweed mitogen for 5-6 days at 37°C and 5% CO,. Wells are harvested and cells and supernatants separated by centrifugation. Replicate cell suspensions, collected onto glass slides with a cytospin centrifuge, are then briefly fixed in cold methanol and stained for cytoplasmic IgG, M and A using fluoresceinated reagents. Both percent and absolute numbers of PWM-induced B-cells can be determined by this method. Supernatant-released Ig can be quantitated by radioimmune assay or by sandwich type ELISA assay, in which plates coated with the IgG fraction of anticanine Ig are reacted with supernatant materials (1 2). Bound-Ig is detected by subsequent reaction with horseradish peroxidase-conjugated anti-Ig and quantitated by comparison of optical density reading of reaction product to that of standard Ig preparation.
T-Lyniphocytes. As with B-lymphocytes, T-lymphocytes in blood and lymphoid organs from most species are easily identified and quantitated with subset-specific monoclonal antibodies and/or FACS analysis. In the absence of defined subset reagents, it is likely that, as in other species, helper T-cells can be identified by rosette formation with erythrocyte-coated IgM complexes (EAp) and suppressor T-cells by EA rosette formation. For dogs, Concanavalin A appears to be a strict T-cell mitogen (1 2). Both soluble protein A and PHA-P are efficient canine T-cell stimulants.
A variety of functional assays define T-cell properties in vitro. Aside from blastogenesis,' the assays fall into two broad groups: those which measure cell : cell interactions, such as mixed leukocyte reactions, helper-suppressor assays and cytotoxic lymphocyte activity (CTL); and those lymphokine-based assays which measure production/release of y i nterferon, tumor necrosis factor, interleukin (1L)-2, 3 and 4, etc. For the former, a general approach will be described for natural killer (NK) cell activity; in the latter case, only production and assay of IL-2 will be described.
Activated helper T-cells are the recognized natural source of IL-2. Interleukin-2 or T-cell growth factor is generated following cellular activation and its main mode of action appears to be in the recruitment and clonal expansion of T-cells bearing IL-2 surface receptors. For IL-2 production (2, 13), lymphocytes, suspensions, depleted of macrophages, are cultured with PHA-P or Con A in 3% (v/v) serum supplemented medium for 48 hours at 37°C in 5% CO, (2). Cell-free supernatants containing IL-2 are then absorbed 1:lO (v/v) with avian erythrocytes to remove residual PHA-P, or a-dmannose is added to negate binding abilities of Con A. Activity can be assayed either by IL-2-enhanced PHA-P-induced blastogenesis on canine thymocytes or by Con A-induced PBL blastogenesis (1 3) or by assay on IL-2 growth dependent murine Tcell lines (J. Bloom, personal communication, 1986) . Nattiral Killer (NK) Cells. The NK cell is widely believed to function as a nonimmune cytotoxic defense mechanism for neoplastic, viral and bacterial diseases. Canine NK cells express the cell membrane marker for Thy-1 and are variably Fc-IgG positive (17) . Cytotoxic activity is easily determined using chr~mium~~-labeled target cells and short-term (4-16 hours) incubation periods. The NK-susceptible target cell of choice for dogs appears to be canine thyroid adenocarcinoma (CTAC) cells (1 1). Cells are labeled with the sodium salt of chromiums~ by incubation of 1500 pCi, specific activity/106 viable cells for 1 hour at 37°C. Washing and resuspension in cold (0-4°C) medium for 2 hours prior to plating markedly reduces spontaneous release of chromium from cells. For dogs, effector : target (E:T) ratios of 30:l work well. A spacer control (i.e., an NK-negative lymphoid cell population such as CT45-S cells) is important for determining uptake of released label by effector PBL. Modulation of NK can be assessed either by changes in release values vs total label or by alterations in percent release with changes in E:T ratios. Acquired ability to lyse NK-resistant targets such as African green monkey (Vero) or MadinDarby canine kidney cells could, in theory, detect alterations in NK activity.
CONCLUSIONS
The goals of this review were to develop an approach to evaluation of immunotoxicity and to describe in vitro and irt vivo techniques which may be useful in implementing a screening program within the pharmaceutical industry. By necessity, the latter has concentrated on assessment of canine immune
